D A Henderson

Summary

Publications

  1. pmc Lessons from the eradication of smallpox: an interview with D. A. Henderson
    D A Henderson
    Center for Health Security, University of Pittsburgh Medical Center, Baltimore, MD 21202, USA
    Philos Trans R Soc Lond B Biol Sci 368:20130113. 2013
  2. ncbi The eradication of smallpox--an overview of the past, present, and future
    Donald A Henderson
    Johns Hopkins University, Center for Biosecurity, 621 East Pratt Street, Baltimore, MD 21202, USA
    Vaccine 29:D7-9. 2011
  3. doi Smallpox virus destruction and the implications of a new vaccine
    D A Henderson
    Center for Biosecurity of UPMC, Baltimore, Maryland 21202, USA
    Biosecur Bioterror 9:163-8. 2011
  4. pmc Bioterrorism as a public health threat
    D A Henderson
    Johns Hopkins University, Baltimore, Maryland, USA
    Emerg Infect Dis 4:488-92. 1998
  5. ncbi Smallpox: clinical and epidemiologic features
    D A Henderson
    Johns Hopkins University, Baltimore, MD, USA
    Med Health R I 85:107-8. 2002
  6. ncbi Countering the posteradication threat of smallpox and polio
    D A Henderson
    The Johns Hopkins Center for Civilian Biodefense Studies, Baltimore, MD, USA
    Clin Infect Dis 34:79-83. 2002
  7. ncbi Recent events and observations pertaining to smallpox virus destruction in 2002
    D A Henderson
    The Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD 21202, USA
    Clin Infect Dis 33:1057-9. 2001
  8. ncbi Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
    D A Henderson
    The Center for Civilian Biodefense Studies, School of Public Health, Johns Hopkins University, Baltimore, MD 21202, USA
    JAMA 281:2127-37. 1999
  9. ncbi Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
    T V Inglesby
    The Center for Civilian Biodefense Studies, School of Medicine, Johns Hopkins University, Baltimore, MD 21202, USA
    JAMA 281:1735-45. 1999
  10. ncbi Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
    T V Inglesby
    Center for Civilian Biodefense Studies, Johns Hopkins University Schools of Medicine, Baltimore, MD 21202, USA
    JAMA 283:2281-90. 2000

Collaborators

Detail Information

Publications27

  1. pmc Lessons from the eradication of smallpox: an interview with D. A. Henderson
    D A Henderson
    Center for Health Security, University of Pittsburgh Medical Center, Baltimore, MD 21202, USA
    Philos Trans R Soc Lond B Biol Sci 368:20130113. 2013
    ..This text is based upon the Unither Baruch Blumberg Lecture, delivered by D. A. Henderson at the University of Oxford in November 2012 and upon conversations and correspondence with Professor Henderson. ..
  2. ncbi The eradication of smallpox--an overview of the past, present, and future
    Donald A Henderson
    Johns Hopkins University, Center for Biosecurity, 621 East Pratt Street, Baltimore, MD 21202, USA
    Vaccine 29:D7-9. 2011
    ..No less important are the growing number of multi-national programs whose foundations rest on the development of active case surveillance to measure achievement and to guide progress - poliomyelitis, measles, guinea worm, and rubella...
  3. doi Smallpox virus destruction and the implications of a new vaccine
    D A Henderson
    Center for Biosecurity of UPMC, Baltimore, Maryland 21202, USA
    Biosecur Bioterror 9:163-8. 2011
    ..This commentary provides approximations of these costs and the incremental contribution that a newly developed vaccine might make in terms of public health security...
  4. pmc Bioterrorism as a public health threat
    D A Henderson
    Johns Hopkins University, Baltimore, Maryland, USA
    Emerg Infect Dis 4:488-92. 1998
    ..For longer-term solutions, the medical community must educate both the public and policy makers about bioterrorism and build a global consensus condemning its use...
  5. ncbi Smallpox: clinical and epidemiologic features
    D A Henderson
    Johns Hopkins University, Baltimore, MD, USA
    Med Health R I 85:107-8. 2002
  6. ncbi Countering the posteradication threat of smallpox and polio
    D A Henderson
    The Johns Hopkins Center for Civilian Biodefense Studies, Baltimore, MD, USA
    Clin Infect Dis 34:79-83. 2002
    ..In these countries, its continued use is advised because of its ability to induce intestinal immunity, its ability to spread to other susceptible household members and to protect them, its ease of administration, and its low cost...
  7. ncbi Recent events and observations pertaining to smallpox virus destruction in 2002
    D A Henderson
    The Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD 21202, USA
    Clin Infect Dis 33:1057-9. 2001
    ....
  8. ncbi Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
    D A Henderson
    The Center for Civilian Biodefense Studies, School of Public Health, Johns Hopkins University, Baltimore, MD 21202, USA
    JAMA 281:2127-37. 1999
    ..To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of smallpox as a biological weapon against a civilian population...
  9. ncbi Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
    T V Inglesby
    The Center for Civilian Biodefense Studies, School of Medicine, Johns Hopkins University, Baltimore, MD 21202, USA
    JAMA 281:1735-45. 1999
    ..To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of anthrax as a biological weapon against a civilian population...
  10. ncbi Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
    T V Inglesby
    Center for Civilian Biodefense Studies, Johns Hopkins University Schools of Medicine, Baltimore, MD 21202, USA
    JAMA 283:2281-90. 2000
    ..The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals following the use of plague as a biological weapon against a civilian population...
  11. ncbi Public health and medical responses to the 1957-58 influenza pandemic
    D A Henderson
    Center for Biosecurity of the University of Pittsburgh Medical Center UPMC, Baltimore, Maryland 21202, USA
    Biosecur Bioterror 7:265-73. 2009
    ..While it cannot be predicted with absolute certainty how the H1N1 pandemic might play out in the U.S. this fall, lessons from the 1957-58 influenza pandemic provide useful and practical insights for current planning and response efforts...
  12. ncbi Hemorrhagic fever viruses as biological weapons: medical and public health management
    Luciana Borio
    Johns Hopkins Center for Civilian Biodefense Strategies, Johns Hopkins Schools of Medicine and Public Health, 111 Market Pl, Suite 830, Baltimore, MD 21202, USA
    JAMA 287:2391-405. 2002
    ..To develop consensus-based recommendations for measures to be taken by medical and public health professionals if hemorrhagic fever viruses (HFVs) are used as biological weapons against a civilian population...
  13. pmc Return of epidemic dengue in the United States: implications for the public health practitioner
    Nidhi Bouri
    Center for Biosecurity of UPMC, Baltimore, MD 21205, USA
    Public Health Rep 127:259-66. 2012
    ..Policy makers should understand the role of mosquito abatement and community engagement in the prevention and control of the disease...
  14. ncbi Disease mitigation measures in the control of pandemic influenza
    Thomas V Inglesby
    Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
    Biosecur Bioterror 4:366-75. 2006
    ..Finally, the article summarizes the authors' judgments of the likely effectiveness and likely adverse consequences of the range of disease mitigation measures and suggests priorities and practical actions to be taken...
  15. ncbi Hospital preparedness for pandemic influenza
    Eric Toner
    Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
    Biosecur Bioterror 4:207-17. 2006
  16. ncbi Improving performance of HVAC systems to reduce exposure to aerosolized infectious agents in buildings; recommendations to reduce risks posed by biological attacks
    Penny J Hitchcock
    Center for Biosecurity of UPMC, Baltimore, MD 21202, USA
    Biosecur Bioterror 4:41-54. 2006
    ....
  17. pmc Eradication: lessons from the past
    D A Henderson
    Johns Hopkins University, Baltimore, MD, USA
    Bull World Health Organ 76:17-21. 1998
    ..This approach, while interesting, fails to recognize many of the important lessons learned and their broad implications for contemporary disease control programmes worldwide...
  18. ncbi Smallpox vaccination: a review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions
    Vincent A Fulginiti
    Department of Pediatrics, University of Arizona, Tucson, USA
    Clin Infect Dis 37:241-50. 2003
    ..The characteristics of smallpox vaccine, the technique of administration, and the expected reactions to primary vaccination and revaccination are outlined in this article...
  19. ncbi Smallpox vaccination: a review, part II. Adverse events
    Vincent A Fulginiti
    Department of Pediatrics, University of Arizona, Tucson, USA
    Clin Infect Dis 37:251-71. 2003
    ..Full understanding of the spectrum of adverse events and of their cause, frequency, identification, prevention, and treatment is imperative. This article describes known and suspected adverse events occurring after smallpox vaccination...
  20. pmc The scientific response to a pandemic
    Gigi Kwik Gronvall
    Center for Biosecurity, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    PLoS Pathog 2:e9. 2006
  21. ncbi The dengue threat to the United States
    Crystal Franco
    Center for Biosecurity of UPMC, Baltimore, Maryland 21202, USA
    Biosecur Bioterror 8:273-6. 2010
    ..The impact of dengue as a public health threat could be lessened through enhanced awareness and reporting of cases, increased support for vector surveillance and control programs, and a greater focus on vaccine development...
  22. ncbi Preventing the use of biological weapons: improving response should prevention fail
    T V Inglesby
    Center for Civilian Biodefense Studies, Johns Hopkins University School of Medicine, Baltimore, MD 21202, USA
    Clin Infect Dis 30:926-9. 2000
    ....
  23. ncbi A conversation with D. A. Henderson. Interview by Jonathan M. Samet
    D A Henderson
    Epidemiology 16:266-9. 2005
  24. ncbi D.A. Henderson: acting globally, thinking locally
    D A Henderson
    Mol Interv 3:242-7. 2003
    ..Again and again, Henderson appears to have the knack for showing up in the right place at the right time with just the right idea...
  25. ncbi Diagnosis and management of smallpox
    Joel G Breman
    Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA
    N Engl J Med 346:1300-8. 2002
  26. ncbi Bioweapons preparedness chief discusses priorities in world of 21st-century biology. Interview by Rebecca Voelker
    D A Henderson
    JAMA 287:573-5. 2002